|
| 2,3,4,6-TETRA-O-BENZYL-D-GLUCONO-1,5-LACTONE Basic information |
Product Name: | 2,3,4,6-TETRA-O-BENZYL-D-GLUCONO-1,5-LACTONE | Synonyms: | 2,3,4,6-TETRAKIS-O-(PHENYLMETHYL)-D-GLUCONIC ACID LACTONE;2,3,4,6-TETRA-O-BENZYL-D-GLUCONO-1,5-LACTONE;5-lactone;D-Gluconic acid,2,3,4,6-tetrakis-O-(phenylMethyl)-, d-lactone;D-Gluconic acid, 2,3,4,6-tetrakis-O-(phenylMethyl)-, δ-lactone;2,3,4,6-Tetrakis-O-(phenylmethyl)-D-Gluconic Acid, D-Lactone;2,3,4,6-Tetra-O-benzyl-D-glucono-1;(3R,4S,5R,6R)-3,4,5-Tris(benzyloxy)-6-(benzyloxymethyl)tetrahydropyran-2-one | CAS: | 13096-62-3 | MF: | C34H34O6 | MW: | 538.63 | EINECS: | | Product Categories: | Pharmaceutical Intermediates | Mol File: | 13096-62-3.mol | |
| 2,3,4,6-TETRA-O-BENZYL-D-GLUCONO-1,5-LACTONE Chemical Properties |
Boiling point | 677.7±55.0 °C(Predicted) | density | 1.22±0.1 g/cm3(Predicted) | storage temp. | Sealed in dry,Room Temperature |
Hazard Codes | Xn | Risk Statements | 22 |
| 2,3,4,6-TETRA-O-BENZYL-D-GLUCONO-1,5-LACTONE Usage And Synthesis |
Uses | 2,3,4,6-Tetra-O-benzyl-D-glucono-1,5-lactone is used as a reactant to synthesize various glucoside containing compounds as selective SGLT2 inhibitors for the treatment of type 2 diabetes mellitus. |
| 2,3,4,6-TETRA-O-BENZYL-D-GLUCONO-1,5-LACTONE Preparation Products And Raw materials |
|